Evaluation of the factor structure of symptoms in patients with schizophrenia

Psychiatry Research

Volumn 197, Issue 3, 2012, Pages 285-289

  Kim, Jong Hoon ^a   Kim, Seong Youn ^a   Lee, Jinyoung ^a   Oh, Kyung Jin ^a   Kim, Young Bo ^a   Cho, Zang Hee ^a  

^a Gachon University   (South Korea)

Author keywords

Factor structure; Five factor model; PANSS; Principal component analysis; Schizophrenia

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CULTURAL FACTOR; DEPRESSION; EXCITEMENT; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; KOREA; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY;

ADULT; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; MALE; MODELS, PSYCHOLOGICAL; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84865076244     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.10.006     Document Type: Article

References (42)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC. Fourth edition.
2. Andreasen N.C. A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. Archives of General Psychiatry 1999, 56:781-787.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbauch J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
4. Bermanzohn P.C., Porto L., Arlow P.B., Pollack S., Stronger R., Siris S.G. Hierarchical diagnosis in chronic schizophrenia: a clinical study of cooccurring syndromes. Schizophrenia Bulletin 2000, 26:517-525.
5. Cuesta M.J., Basterra V., Sanchez-Torres A., Peralta V. Controversies surrounding the diagnosis of schizophrenia and other psychoses. Expert Review of Neurotherapeutics 2009, 9:1475-1486.
6. Emsley R., Rabinowitz J., Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003, 61:47-57.
7. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) 1996, Clinician Version American Psychiatric Press, Washington, DC.
8. Fitzgerald P., De Castella A., Brewer K., Filia K., Collins J., Davey P., Rolfe T., Kulkarni J. A confirmatory factor analytic evaluation of the pentagonal PANSS model. Schizophrenia Research 2003, 61:97-104.
9. Fleischhacker W.W., Rabinowitz J., Kemmler G., Eerdekens M., Mehnert A. Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. The British Journal of Psychiatry 2005, 187:131-136.
10. Fresán A., De la Fuente-Sandoval C., Loyzaga C., García-Anaya M., Meyenberg N., Nicolini H., Apiquian R. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients. Schizophrenia Research 2005, 72:123-129.
11. Guy W. ECDEU Assessment Manual for Psychopharmacology 1976, US Dept of Health, Education, and Welfare, Bethesda.
12. Harris R.J. A Primer of Multivariate Statistics 1975, Academic Press, New York.
13. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., Fleischhacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. The Journal of Clinical Psychiatry 2004, 65:932-939.
14. Inada T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage 1996, Seiwa Shoten Publishers, Tokyo.
15. Inada T., Yagi G., Miura S. Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol. Schizophrenia Research 2002, 57:227-238.
16. Kawasaki Y., Maeda Y., Sakai N., Higashima M., Urata K., Yamaguchi N., Kurachi M. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatrica Scandinavica 1994, 89:399-404.
17. Kay S.R., Opler L.A. Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) 1988, Albert Einstein College of Medicine, New York.
18. Kay S.R., Sevy S. Pyramidical model of schizophrenia. Schizophrenia Bulletin 1990, 16:537-545.
19. Kay S.R., Fisbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
20. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophrenia Bulletin 2007, 33:912-920.
21. Kim J.H., Jung H.Y., Kang U.G., Jeong S.H., Ahn Y.M., Byun H.J., Ha K.S., Kim Y.S. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders. Movement Disorders 2002, 17:1354-1359.
22. Kim J.H., Lee B.C., Park H.J., Ahn Y.M., Kang U.G., Kim Y.S. Subjective emotional experience and cognitive impairment in drug-induced akathisia. Comprehensive Psychiatry 2002, 43:456-462.
23. Kim J.H., Ann J.H., Kim M.J. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia. Comprehensive Psychiatry 2010, 51:165-170.
24. Lançon C., Aghababian V., Llorca P.M., Auquier P.M. Factorial structure of the positive and negative syndrome scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatrica Scandinavica 1998, 97:369-376.
25. Lançon C., Auquier P., Nayt G., Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research 2000, 42:231-239.
26. Lehoux C., Gobeil M.H., Lefèbvre A.A., Maziade M., Roy M.A. The five-factor structure of the PANSS: a critical review of its consistency across studies. Clinical Schizophrenia & Related Psychoses 2009, 3:103-110.
27. Levine S.Z., Rabinowitz J. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale. Journal of Clinical Psychopharmacology 2007, 27:431-436.
28. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S. A new five factor model of schizophrenia. Psychiatric Quarterly 1994, 65:299-322.
29. Lindenmayer J.P., Growowski S., Hymn R.B. Five-factor model of schizophrenia: replication across samples. Schizophrenia Research 1995, 14:229-234.
30. Lindström E., von Knorring L. Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia. Nordic Journal of Psychiatry 1993, 47:257-263.
31. Lykouras L., Oulis P., Psarros K., Dasklopoulou E., Botsis A., Christodoulou G.N., Stefanis C. Five-factor model of schizophrenic pathology: how valid is it?. European Archives of Psychiatry and Clinical Neuroscience 2000, 250:93-100.
32. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. The Journal of Clinical Psychiatry 1997, 58:538-546.
33. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the Positive and Negative Syndrome Scale. Schizophrenia Bulletin 2000, 26:167-177.
34. Munro B.H. Statistical Methods for Health Care Research 2004, Lippincott Williams & Wilkins, Philadelphia. fifth ed.
35. Naber D., Moritz S., Lambert M., Pajonk F.G., Holzbach R., Mass R., Andresen B. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophrenia Research 2001, 50:79-88.
36. Obermeier M., Mayr A., Schennach-Wolff R., Seemüller F., Möller H.J., Riedel M. Should the PANSS be rescaled?. Schizophrenia Bulletin 2010, 36:455-460.
37. Salokangas R.K. Symptom dimensions and outcome in schizophrenia. World Psychiatry 2003, 2:172-178.
38. Siris S.G. Depression in schizophrenia: perspective in the era of atypical antipsychotic agents. The American Journal of Psychiatry 2000, 157:1379-1389.
39. van der Gaag M., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Cuijpers A., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophrenia Research 2006, 85:280-287.
40. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology 1997, 30:263-274. The PANSS Study Group.
41. Yi J.S., Ahn Y.M., Shin H.K., An S.K., Joo Y.H., Kim S.H., Yoon D.J., Jho K.H., Koo Y.J., Lee J.Y., Cho I.H., Park Y.H., Kim K.S., Kim Y.S. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. Journal of Korean Neuropsychiatric Association 2001, 40:1090-1105.
42. Zisook S., McAdams L.A., Kuck J., Harris M.J., Bailey A., Patterson T.L., Judd L.L., Jeste D.V. Depressive symptoms in schizophrenia. The American Journal of Psychiatry 1999, 156:1736-1743.